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Abstract: Following silicone injection, end organ toxicity can occur. To our knowledge 
this report documents the first case of silicone embolization in the Caribbean and serves 
to highlight an emergent danger associated with its illicit use for cosmetic purposes in this 
region.
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Case
A 38-year-old female presented to the emergency department with sudden onset 
of shortness of breath, chest pain, and hemoptysis. On examination, the patient 
was   afebrile and positive findings included tachycardia (pulse rate of 130 beats per 
minute), tachypnea (respiratory rate of 35 breaths per minute), and SpO2 by pulse 
oximetry was 86% on room air. The trachea was central and there was symmetrical 
chest expansion, with resonance on percussion and clear breath sounds bilaterally. 
Arterial blood gas results revealed hypoxemia and a respiratory alkalosis (pH: 7.46; 
pCO2: 30 mmHg; pO2: 55 mmHg; HCO3: 22 mmol/L; SaO2: 88%). Initial chest X-ray 
was normal and CT pulmonary angiography (CTPA) showed no evidence of pulmo-
nary embolism, but there was basal and peripheral interstitial shadowing bilaterally 
(Figure 1). The clinical impression at that time was acute interstitial pneumonia with 
possible   pulmonary embolism (PE). High flow O2 was administered together with 
intravenous levofloxacin 750 mg orally and intravenous hydrocortisone 200 mg every 
6 hours. Since the patient’s coagulation profile was normal and there were no obvious 
vascular deformities noted in CT scan, subcutaneous enoxaparin 60 mg twice daily 
was also started. By day 3, her condition had worsened with increasing hemoptysis 
and decreasing SpO2 ranging from 83% to 85%. Repeat arterial blood gas was con-
sistent with worsening hypoxemia and partially compensated respiratory alkalosis 
(pH: 7.48; pCO2: 26 mmHg; pO2: 50 mmHg; HCO3: 18 mmol/L; SaO2: 80%). Chest 
examination now revealed crepitations bilaterally in both bases, and chest X-ray 
showed bilateral basal nonhomogeneous opacities with obliteration of costophrenic 
angles (Figure 2). The patient was repeatedly counseled about the seriousness of her 
condition and further inquiry revealed that the patient had received silicone injection 
on her buttocks, 6 hours prior to her presentation. Approximately 500 mL of silicone 
was administered by an unlicensed aesthetician. Over the next few days, the patient’s International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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anticoagulated with   warfarin for 6 months. Radiological 
resolution and spirometry normalization (Table 1) occurred 
after 4 weeks, whereas, elevated AST were normalized only 
after 8 weeks.
Discussion
Liquid silicone is a polymer (dimethylpolysiloxane) that has 
been widely used for aesthetic purposes since the 1960s.1 
Despite the dangers and long history of fatalities, disease, 
and disfigurement caused by silicone injection, its illicit use 
is still common around the world.
Two distinct patterns of clinical presentation are seen 
after injection of silicone enters the systemic circulation: 
either respiratory distress, which occurred in this present 
report, or severe neurological changes.2 The first case of 
Figure  1  CT  pulmonary  angiography  showing  basal  and  peripheral  interstitial 
shadowing bilaterally.
Figure 2 Chest X-ray showing bilateral patchy opacification.
Figure 3 Hemoptysis contents with whitish material admixed on the sputum.
Table 1 spirometry on day 14 (after hemoptysis control) and at 
follow-up clinic (after 1 month)
Day 14 1 month
FeV1/FVC% 90.8 86.5
FeV1 1.38 L (61% of predicted) 1.86 L (82% of predicted)
FVC 1.52 L (58% of predicted) 2.15 (82% of predicted)
FeF25%–75% 2.29 (62% of predicted) 2.74 (75% of predicted)
Abbreviations: FeV1, forced expiratory volume in the first second of expiration; 
FVC, forced vital capacity; FEF, forced expiratory flow, midexpiratory phase.
oxygenation improved but she had persistent hemoptysis, 
resulting in a drop in   hemoglobin from 11 g/dL to 9 g/dL 
requiring transfusion with two units of packed red blood 
cells. It was also noted that there was whitish material 
admixed on the sputum. (Figure 3) This was sent for spu-
tum cytology which revealed inflammatory cells containing 
neutrophils and lymphocytes. Of note, her repeat chemistry 
at this time showed an elevated aspartate aminotransferase 
(AST) of 110. By day 7, the patient was showing clinical 
signs of improvement with SpO2 ranging from 93% to 95%. 
By day 13, the patient had no hemoptysis and her SpO2 was 
98% on room air. Spirometry on day 14 revealed moderate 
restrictive defect (Table 1) and she was discharged from 
hospital. At follow-up clinic, the patient was symptom-
free. She was continued on oral steroids for 4 weeks and International Journal of General Medicine
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pneumonitis following silicone injection was described 
in 1975.1 The acute form of pneumonitis following silicone 
injection, as seen in this patient, appears immediately or 
within 24 hours after injection, with sudden-onset dyspnea, 
tachycardia, tachypnea, fever, and, occasionally, chest pain or 
hemoptysis. The pathogenesis of acute pneumonitis involves 
a process of pulmonary embolism following the diffusion 
of the silicone into the circulatory system, encouraged by 
high local tissue pressure, massages, migration, or direct 
injection.3
The index case presented with severe respiratory distress 
a few hours after silicone injection. With incomplete history 
from the patient, PE with acute interstitial lung inflammation 
was suspected. Now, a negative multidetector CT (CTPA) 
is an adequate criterion for excluding PE in patients with 
a nonhigh clinical probability of PE.4 However, this case 
belonged to a high probability class and subsegmental emboli 
were feasible. Whether patients with a negative CT and a 
high clinical probability should be further investigated by 
other methods is controversial. Moreover currently there 
are no straightforward accepted guidelines for treatment of 
subsegmental PE.
Additionally silicone embolization to the lung is 
associated with alveolar hemorrhage.5 In the present case, 
  hemoptysis might be secondary to alveolar hemorrhage 
and/or pulmonary infarction, which was managed with 
two units of packed red blood cells transfusion. Normal 
connective tissue and coagulation profiles, renal func-
tions, and   anatomically normal vasculature in CT scan 
precluded the possibility of other causes for pulmonary 
hemorrhage. Despite its high value, bronchoscopy was 
deferred due to potential worsening hypoxemia. It is a 
well-known fact that arterial oxygen tension routinely 
decreases by 10 to 20 mmHg after uncomplicated fiber-
optic bronchoscopy, and hypoxemic patients are at high 
risk for developing respiratory failure or serious cardiac 
arrhythmias.6,7
Systemic complications have also been reported after 
silicone use and include mastitis, granulomatous hepatitis, 
connective tissue disease, lymphadenopathy, and acute febrile 
reaction.1 This patient’s persistently elevated AST may have 
occurred on account of silicone migration to the liver, but 
conservative treatment was undertaken and resolution was 
complete.
This case highlights a serious complication of an 
apparently innocuous process, of which clinicians and the 
public should be made aware. Clandestine injection of 
silicone for body enhancement is common and clinicians 
should be aware of potential complications.8  A history of 
cosmetic   procedures involving silicone should be considered 
in unusual cases of the nature presented here.
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